152 related articles for article (PubMed ID: 33864105)
41. Diarylheptanoid compounds from Alnus nepalensis express in vitro and in vivo antifilarial activity.
Yadav D; Kushwaha V; Saxena K; Verma R; Murthy PK; Gupta MM
Acta Trop; 2013 Dec; 128(3):509-17. PubMed ID: 23911333
[TBL] [Abstract][Full Text] [Related]
42. Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi.
Tchakouté VL; Bronsvoort M; Tanya V; Renz A; Trees AJ
Parasitology; 1999 Feb; 118 ( Pt 2)():195-9. PubMed ID: 10028534
[TBL] [Abstract][Full Text] [Related]
43. The use of monoclonal antibody-based ELISAs to monitor chemotherapeutic effects in the bovine-Onchocerca gibsoni drug screen.
More SJ; Copeman DB
Trop Med Parasitol; 1991 Mar; 42(1):17-20. PubMed ID: 2052850
[TBL] [Abstract][Full Text] [Related]
44. Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis.
Jawahar S; Tricoche N; Bulman CA; Sakanari J; Lustigman S
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009064. PubMed ID: 33600426
[TBL] [Abstract][Full Text] [Related]
45. Differential susceptibility of Onchocerca ochengi adult male worms to flubendazole in gerbils and hamsters.
Mbah GE; Ayiseh RB; Monya E; Ndi EM; Njotu FN; Kulu TK; Sakanari J; Lustigman S; Cho-Ngwa F
Parasitol Res; 2024 Apr; 123(4):186. PubMed ID: 38634933
[TBL] [Abstract][Full Text] [Related]
46. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of microfilaricidal and macrofilaricidal compounds.
Horton J
Trans R Soc Trop Med Hyg; 1998; 92(6):688. PubMed ID: 10326128
[No Abstract] [Full Text] [Related]
48. Histological examination of onchocercomata after therapy with ivermectin.
Albiez EJ; Walter G; Kaiser A; Ranque P; Newland HS; White AT; Greene BM; Taylor HR; Büttner DW
Trop Med Parasitol; 1988 Jun; 39(2):93-9. PubMed ID: 3175472
[TBL] [Abstract][Full Text] [Related]
49. In vitro drug screening in isolated male Onchocerca gibsoni using motility suppression.
Nowak M; Hutchinson GW; Copeman DB
Trop Med Parasitol; 1987 Jun; 38(2):128-30. PubMed ID: 3629135
[TBL] [Abstract][Full Text] [Related]
50.
Ignagali BB; Galani Tietcheu BR; Betrosse T; Kamaya B; Ndjonka D
J Parasitol Res; 2024; 2024():2119056. PubMed ID: 38328477
[TBL] [Abstract][Full Text] [Related]
51. Metrifonate in onchocerciasis and lymphatic filariasis.
Abaru DE; McMahon JE
Tropenmed Parasitol; 1978 Jun; 29(2):175-7. PubMed ID: 675839
[TBL] [Abstract][Full Text] [Related]
52. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
Duke BO
Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
[TBL] [Abstract][Full Text] [Related]
53. Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo.
Tagboto SK; Townson S
Ann Trop Med Parasitol; 1996 Oct; 90(5):497-505. PubMed ID: 8915126
[TBL] [Abstract][Full Text] [Related]
54. Electron microscopic studies on the effects of CGP 6140 and CGP 20376 on microfilariae and third stage larvae of Onchocerca volvulus.
Strote G
Trop Med Parasitol; 1989 Sep; 40(3):304-10. PubMed ID: 2617038
[TBL] [Abstract][Full Text] [Related]
55. Further evidence of the cross-reactivity of the Binax NOW® Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi.
Wanji S; Amvongo-Adjia N; Njouendou AJ; Kengne-Ouafo JA; Ndongmo WP; Fombad FF; Koudou B; Enyong PA; Bockarie M
Parasit Vectors; 2016 May; 9():267. PubMed ID: 27151313
[TBL] [Abstract][Full Text] [Related]
56. Preliminary evaluations of 3-dimensional human skin models for their ability to facilitate in vitro the long-term development of the debilitating obligatory human parasite Onchocerca volvulus.
Malkmus C; Jawahar S; Tricoche N; Lustigman S; Hansmann J
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008503. PubMed ID: 33151944
[TBL] [Abstract][Full Text] [Related]
57. Amocarzine investigated as oral onchocercacidal drug in 272 adult male patients from Guatemala. Results from three dose regimens spread over three days.
Zea-Flores G; Beltranena F; Poltera AA; Lopez M; Moran M; Zea-Flores CE; de Ramirez I; Lecaillon JB; Zak F; Palomo M
Trop Med Parasitol; 1991 Sep; 42(3):240-62. PubMed ID: 1801152
[TBL] [Abstract][Full Text] [Related]
58. Ivermectin effect on microfilariae of Onchocerca volvulus after a single oral dose in humans.
Soboslay PT; Newland HS; White AT; Erttmann KD; Albiez EJ; Taylor HR; Williams PN; Greene BM
Trop Med Parasitol; 1987 Mar; 38(1):8-10. PubMed ID: 3602843
[TBL] [Abstract][Full Text] [Related]
59. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients.
Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT
Trans R Soc Trop Med Hyg; 1999; 93(2):189-94. PubMed ID: 10450448
[TBL] [Abstract][Full Text] [Related]
60. Ivermectin treatment of ocular onchocerciasis.
Taylor HR
Acta Leiden; 1990; 59(1-2):201-6. PubMed ID: 2198751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
